李靜欣

職稱主治醫師

專長一般放射治療
學歷2015 長庚大學醫學系畢業
2020 英國鄧迪大學醫學教育碩士畢業
經歷2014~2015 林口長庚醫院實習醫師
2015~2016 林口長庚醫院PGY住院醫師
2016~2020 林口長庚醫院放射腫瘤科住院醫師
2020~    林口長庚醫院放射腫瘤科主治醫師


參與學會台灣放射腫瘤學會(TASTRO)
發表論文
  • Lee, C.-H., P.-J. Chen, H.-Y. Lai, C.-Y. Lee, K.-H. Fan, N.-M. Tsang and J. T.-C. Chang (2020). "A scoping review of medical education research for residents in radiation oncology." BMC medical education 20(1): 1-8.
  • Chen, P.-J., W.-K. Yap, Y.-C. Chang, C.-K. Tseng, Y.-K. Chao, J. C.-H. Hsieh, P.-C. Pai, C.-H. Lee, C.-K. Yang and A. T.-Y. Ho (2020). "Prognostic value of lymph node to primary tumor standardized uptake value ratio in unresectable esophageal cancer." BMC Cancer 20(1): 1-9.
  • Cheng, J.-Y., C.-M. Liu, Y.-M. Wang, H.-C. Hsu, E.-Y. Huang, T.-T. Huang, C.-H. Lee, S.-P. Hung and B.-S. Huang (2020). "Proton versus photon radiotherapy for primary hepatocellular carcinoma: A propensity-matched analysis."
  • Hsieh, C.-E., B. P. Venkatesulu, C.-H. Lee, S.-P. Hung, P.-F. Wong, S. P. Aithala, B. K. Kim, A. Rao, J. T.-C. Chang and N.-M. Tsang (2019). "Predictors of radiation-induced liver disease in eastern and western patients with hepatocellular carcinoma undergoing proton beam therapy." International Journal of Radiation Oncology* Biology* Physics 105(1): 73-86.
  • Hung, S.-P., B.-S. Huang, C.-E. Hsieh, C.-H. Lee, N.-M. Tsang, J. T.-C. Chang, J.-S. Chen, W.-C. Chou, J.-H. Tseng and J.-H. Hong (2020). "Clinical Outcomes of Patients With Unresectable Cholangiocarcinoma Treated With Proton Beam Therapy." American Journal of Clinical Oncology 43(3): 180-186.
  • Lee, C.-H., S.-P. Hung, J.-H. Hong, J. T.-C. Chang, N.-M. Tsang, K.-M. Chan, J.-H. Tseng, S.-C. Huang, S.-M. Lin and J.-M. Lien (2018). "How small is TOO small? New liver constraint is needed—Proton therapy of hepatocellular carcinoma patients with small normal liver." PloS one 13(9): e0203854.
  • Hsieh, C.-E., J.-H. Hong, C.-C. Lin, C.-H. Lee, S.-P. Hung, C.-Y. Chou, C.-M. Chen and J.-H. Tseng (2018). "Complete response of unresectable icteric-type hepatocellular carcinoma to hypofractionated proton beam therapy with concurrent plus adjuvant sorafenib: a case report."
  • Lee, C.-Y., H.-Y. Lai, C.-H. Lee and S.-T. Lee (2017). "Does one size fit all? Examining the application of neurosurgery residency milestones developed in the United States to a Taiwanese culture." World Neurosurgery 104: 499-508.
  • Lin, C.-H., W.-C. Chou, Y.-Y. Wu, C.-Y. Lin, K.-P. Chang, C.-T. Liao, T.-Y. Ho, C.-M. Yeh, C.-J. Liu, S.-P. Hung, C.-H. Lee, P.-J. Chen, Y.-C. Chou, K.-H. Fan, B.-S. Huang, J. Tung-Chieh Chang, C.-C. Wang and N.-M. Tsang (2021). "Prognostic significance of dynamic changes in lymphocyte-to-monocyte ratio in patients with head and neck cancer treated with radiotherapy: results from a large cohort study." Radiotherapy and Oncology 154: 76-86.